PDLI Key Stats
- PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officer... May 22
- July Options Now Available For PDL BioPharma May 20
- PDL BIOPHARMA, INC. Financials May 17
- Jim Cramer: Buy Google, First Solar, Marathon Petroleum, and These 2 Stocks May 16
- 2 Scariest Dividend Stocks in Health Care May 16
- Cramer's Lightning Round - SunPower Has Staying Power (5/15/13) May 16
- 'Mad Money' Lightning Round: Ford Is a Buy May 16
- Lightning Round: Berkshire Hathaway, Ford & More May 15
- Theravance Looks to Reward Shareholders by Splitting Into Two Distinct Companies Fool May 15
- 2 Scariest Dividend Stocks in Health Care Fool May 15
PDLI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). PDL BioPharma is up 40.07% over the last year vs S&P 500 Total Return up 28.68%, Biogen Idec up 75.99%, and Elan down 6.20%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for PDLI
Pro Report PDF for PDLI
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download PDLI Pro Report PDF
Pro Strategies Featuring PDLI
Did PDL BioPharma make it into our Pro Portfolio Strategies?